Our science

More than a 100-year experience with drug development and discovery

More than 700 scientists and specialists work within research and development in LEO Pharma to develop new treatments. Together, we take the drugs all the way - from research to registration.

Research and development

We have more than a 100-year of experience with drug development and discovery

Our innovation ecosystem

We are committed to making great solutions through innovation

Clinical trial disclosure

We are transparent about our clinical trials' results

From idea to registration

Our continuous growth depends on the achievements of our Research and Development

Kim Kjoeller_ Executive Vice President_ GlobalRD

We work relentlessly to help patients with skin diseases. We are driven by our desire to offer new, innovative medicines better and faster than anyone else, and our aspiration is to help 125 million patients by 2025.
Kim Kjøller
Executive Vice President
Global Research

NEWS ARTICLE

LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment

Andernach, DE, and Ballerup, DK, March 19, 2019: LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma A/S, a global leader in dermatology, today announced that the companies will start the clinical trial of microarray patches for the local intradermal treatment of psoriasis.

Read the full story

NEWS ARTICLE

LEO Pharma and Elektrofi expand partnership to co-develop new antibodies with the aim of achieving improvements in drug delivery within dermatology

Ballerup, April 9, 2019: LEO Pharma A/S, a global leader in medical dermatology and Elektrofi, a Boston-based biotechnology company focused on drug formulation and delivery innovations, today announced an expansion of the two companies' partnership agreement (signed in 2017) to further include antibodies from LEO Pharma's pipeline with the aim of achieving improvements in drug delivery within dermatology.